pyrazinamide has been researched along with Orphan Diseases in 1 studies
pyrazinecarboxamide : A monocarboxylic acid amide resulting from the formal condensation of the carboxy group of pyrazinoic acid (pyrazine-2-carboxylic acid) with ammonia. A prodrug for pyrazinoic acid, pyrazinecarboxamide is used as part of multidrug regimens for the treatment of tuberculosis.
Orphan Diseases: Rare diseases that have not been well studied.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bozzola, E | 1 |
| Bozzola, M | 1 |
| Magistrelli, A | 1 |
| Calcaterra, V | 1 |
| Larizza, D | 1 |
| Lancella, L | 1 |
| Villani, A | 1 |
1 other study available for pyrazinamide and Orphan Diseases
| Article | Year |
|---|---|
Paediatric tubercular spinal abscess involving the dorsal, lumbar and sacral regions and causing spinal cord compression.
Topics: Adolescent; Antitubercular Agents; Drug Therapy, Combination; Epidural Abscess; Humans; Isoniazid; L | 2013 |